Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma.

被引：65

作者：

Rajkumar, SV ^{[1
]}

Gertz, MA ^{[1
]}

Witzig, TE ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2000年 / 343卷 / 13期

关键词：

D O I：

10.1056/NEJM200009283431315

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：972 / 973

页数：2

共 6 条

[1] Thalidomide-induced toxic epidermal necrolysis [J].

Horowitz, SB ;

Stirling, AL .

PHARMACOTHERAPY, 1999, 19 (10) :1177-1180

[2]

Rajkumar SV, 1999, BLOOD, V94, p316A

[3] Antitumor activity of thalidomide in refractory multiple myeloma. [J].

Singhal, S ;

Mehta, J ;

Desikan, R ;

Ayers, D ;

Roberson, P ;

Eddlemon, P ;

Munshi, N ;

Anaissie, E ;

Wilson, C ;

Dhodapkar, M ;

Zeldis, J ;

Barlogie, B ;

Siegel, D ;

Crowley, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1565-1571

[4]

Singhal S, 2000, NEW ENGL J MED, V342, P364

[5] Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin [J].

Viard, I ;

Wehrli, P ;

Bullani, R ;

Schneider, P ;

Holler, N ;

Salomon, D ;

Hunziker, T ;

Saurat, JH ;

Tschopp, J ;

French, LE .

SCIENCE, 1998, 282 (5388) :490-493

[6] Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis [J].

Wolkenstein, P ;

Latarjet, J ;

Roujeau, JC ;

Duguet, C ;

Boudeau, S ;

Vaillant, L ;

Maignan, M ;

Schuhmacher, MH ;

Milpied, B ;

Pilorget, A ;

Bocquet, H ;

Brun-Buisson, C ;

Revuz, J .

LANCET, 1998, 352 (9140) :1586-1589

← 1 →